William Blair analyst Andy T. Hsieh downgraded Cardiff Oncology (NASDAQ: CRDF) from Outperform to Market Perform.The analyst comments: “After markets ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE